Drug Profile
Cisplatin/epinephrine injectable gel - Novartis
Alternative Names: CDDP TI; Cisplatin therapeutic implant; cisplatin-e therapeutic implant; IntraDose-CDDP™; MPI-5010Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Matrix Pharmaceutical
- Developer Novartis
- Class Antineoplastics; Catecholamines; Ethanolamines; Platinum complexes
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast cancer; Cancer metastases; Head and neck cancer; Liver cancer; Lung cancer; Malignant melanoma; Oesophageal cancer; Sarcoma; Solid tumours